Multi-criteria decision making and its application to in silico discovery of vaccine candidates for Toxoplasma gondii

IF 4.5 3区 医学 Q2 IMMUNOLOGY
John T. Ellis , Paul J. Kennedy
{"title":"Multi-criteria decision making and its application to in silico discovery of vaccine candidates for Toxoplasma gondii","authors":"John T. Ellis ,&nbsp;Paul J. Kennedy","doi":"10.1016/j.vaccine.2025.127242","DOIUrl":null,"url":null,"abstract":"<div><div>Vaccine discovery against eukaryotic parasites is not trivial and few exist. Reverse vaccinology is an <em>in silico</em> vaccine discovery approach, designed to identify vaccine candidates from the thousands of protein sequences encoded by a target genome. Previously, we produced the Vacceed bioinformatics pipeline for identification of parasite membrane and excreted/secreted proteins that were likely be exposed to the hosts immune system. More recently, we improved upon machine learning as the final decision-making process to identify parasite proteins that induce a protective response in an animal model. Subsequently, we combined Vacceed with metrics on B and T cell epitope types to produce a new <em>in silico</em> discovery workflow. In this study we extend this <em>in silico</em> workflow to the developability of proteins as vaccines by the incorporation of metrics on the physicochemical properties of proteins. To demonstrate this process, every <em>Toxoplasma gondii</em> protein was ranked in its capacity to provide exposure to the immune system (Vacceed exposure score), presence of epitopes and solubility characteristics by several multicriteria decision making (MCDM) tools (such as TOPSIS, VIKOR and MABAC). A consensus rank was subsequently generated from the results of these tools using a variety of aggregate ranking methods. Levels of uncertainty in the aggregate protein rankings was assessed by conformal interval prediction in association with a machine learning model. Several of the top ranked proteins identified by this approach were novel, uncharacterized membrane transporters or proteins associated with RNA metabolism. In conclusion, MCDM automated the decision making using well known algorithms while conformal prediction intervals varied significantly across the 8000+ proteins of <em>T. gondii</em>. Highly ranked proteins (<em>e.g.</em> the top 100) typically generated low prediction intervals, providing high levels of confidence in their ranks.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"58 ","pages":"Article 127242"},"PeriodicalIF":4.5000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25005390","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Vaccine discovery against eukaryotic parasites is not trivial and few exist. Reverse vaccinology is an in silico vaccine discovery approach, designed to identify vaccine candidates from the thousands of protein sequences encoded by a target genome. Previously, we produced the Vacceed bioinformatics pipeline for identification of parasite membrane and excreted/secreted proteins that were likely be exposed to the hosts immune system. More recently, we improved upon machine learning as the final decision-making process to identify parasite proteins that induce a protective response in an animal model. Subsequently, we combined Vacceed with metrics on B and T cell epitope types to produce a new in silico discovery workflow. In this study we extend this in silico workflow to the developability of proteins as vaccines by the incorporation of metrics on the physicochemical properties of proteins. To demonstrate this process, every Toxoplasma gondii protein was ranked in its capacity to provide exposure to the immune system (Vacceed exposure score), presence of epitopes and solubility characteristics by several multicriteria decision making (MCDM) tools (such as TOPSIS, VIKOR and MABAC). A consensus rank was subsequently generated from the results of these tools using a variety of aggregate ranking methods. Levels of uncertainty in the aggregate protein rankings was assessed by conformal interval prediction in association with a machine learning model. Several of the top ranked proteins identified by this approach were novel, uncharacterized membrane transporters or proteins associated with RNA metabolism. In conclusion, MCDM automated the decision making using well known algorithms while conformal prediction intervals varied significantly across the 8000+ proteins of T. gondii. Highly ranked proteins (e.g. the top 100) typically generated low prediction intervals, providing high levels of confidence in their ranks.
多准则决策及其在刚地弓形虫候选疫苗计算机发现中的应用
针对真核寄生虫的疫苗的发现并非微不足道,而且很少存在。反向疫苗学是一种计算机疫苗发现方法,旨在从靶基因组编码的数千个蛋白质序列中识别候选疫苗。之前,我们制作了Vacceed生物信息学管道,用于鉴定可能暴露于宿主免疫系统的寄生虫膜和排泄/分泌蛋白。最近,我们改进了机器学习作为最终决策过程,以识别在动物模型中诱导保护性反应的寄生虫蛋白。随后,我们将Vacceed与B细胞和T细胞表位类型的指标结合起来,产生了一种新的计算机发现工作流程。在这项研究中,我们通过结合蛋白质的物理化学性质的指标,将这种硅片工作流程扩展到蛋白质作为疫苗的可开发性。为了证明这一过程,通过几种多标准决策(MCDM)工具(如TOPSIS、VIKOR和MABAC),对每种弓形虫蛋白根据其暴露于免疫系统的能力(Vacceed暴露评分)、表位的存在和溶解度特征进行了排名。随后,使用各种综合排名方法从这些工具的结果中生成共识排名。通过与机器学习模型相关联的适形区间预测来评估总蛋白质排名的不确定性水平。通过这种方法鉴定的一些排名靠前的蛋白质是新的,未表征的膜转运蛋白或与RNA代谢相关的蛋白质。总之,MCDM使用已知算法自动化决策,而弓形虫8000多个蛋白的适形预测间隔差异很大。排名高的蛋白质(例如前100名)通常产生较低的预测间隔,为其排名提供高水平的信心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信